Spero Therapeutics Current Assets

Spero Therapeutics (SPRO) currently reports a current assets of $58M as of March 2026. That compares with $75M in the prior-year period — down 22.9% year over year. Use the charts on this page to explore Spero Therapeutics's current assets history and peer comparisons.

Spero Therapeutics's current assets decreased from $75M to $58M — a 22.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Spero Therapeutics reported $58M in current assets as of March 2026. That compares with $75M in the prior-year period — down 22.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $58M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Spero Therapeutics, and consider following SPRO for alerts when major investors trade the stock.

Spero Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $58M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SPRO with unrelated industries.